Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.22
(
-0.21%
)
Bitcoin
70,734.99
(
1.20%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 104628

Monday, 09/20/2010 2:57:56 PM

Monday, September 20, 2010 2:57:56 PM

Post# of 257262

…claiming that they will convert the entire Copaxone market to the 0.5ml by EOY 2011.

Total BS, IMHO.

What is it about Copaxone in a more concentrated form (0.5ml vs 1.0ml) that is patentable?

Any patents that issue on this product probably won’t stand up to scrutiny; however, Teva may be able to get three years of Hatch-Waxman marketing exclusivity for a new formulation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now